Assessing the Risk of Leukemia Recurrence After Childhood Recovery

Q: Assessing the Risk of Leukemia Recurrence After Childhood Recovery

Hello： First of all, after so many years, I hope your leukemia has improved. <br>However, you should have been going to the hematology department for blood tests once a year for follow-up. <br>Secondly, since you have anemia, you should also visit the hematology department to get

What is the likelihood of leukemia relapse?

Hello Doctor: I was diagnosed with acute lymphoblastic leukemia in my childhood and have been in remission since then.
I stopped follow-up during middle school until last year and this year when I underwent a health check at work.
Last year, my hemoglobin levels were low, which I thought was due to anemia.
This year, my hemoglobin is still low, and there is variability in my red blood cell size.
The company’s nurse recommended that I see a hematologist for a detailed examination, although my platelet counts are normal.
Should I go to the hematology-oncology department for further evaluation? Also, is there a possibility of relapse?

Han Baobao, 20~29 year old female. Ask Date: 2018/08/01

Dr. Chen Yunfang reply Oncology

Hello: First of all, after so many years, I hope your leukemia has improved.
However, you should have been going to the hematology department for blood tests once a year for follow-up.
Secondly, since you have anemia, you should also visit the hematology department to get medication for treatment.
So, please make an appointment with the hematology department as soon as possible.
Thank you.

Reply Date: 2018/08/01

More Info

Assessing the risk of leukemia recurrence after childhood recovery is a significant concern for many survivors and their families. Acute Lymphoblastic Leukemia (ALL) is one of the most common types of leukemia in children, and while many children achieve remission, the fear of recurrence can linger long after treatment has ended.

Firstly, it is essential to understand that the risk of recurrence varies based on several factors, including the initial risk classification of the leukemia, the treatment received, and the duration of remission. In your case, having been diagnosed with ALL and now experiencing low hemoglobin levels, it is prudent to follow up with a hematologist-oncologist. They can perform a thorough evaluation, including blood tests, bone marrow biopsies, and possibly imaging studies, to assess your current health status and rule out any recurrence of leukemia or other hematological disorders.

Regarding your concern about the possibility of recurrence, studies indicate that the risk of relapse is highest within the first few years after treatment. However, as time passes, the likelihood of recurrence diminishes significantly. For example, most relapses occur within the first five years post-treatment, and those who remain in remission beyond this period generally have a much lower risk of relapse. Nevertheless, it is crucial to remain vigilant and report any new symptoms or changes in health to your healthcare provider.

The symptoms you mentioned, such as low hemoglobin levels and variations in red blood cell size, could be indicative of several conditions, including anemia or other blood disorders, but they do not automatically suggest a recurrence of leukemia. Normal platelet counts are a positive sign, as thrombocytopenia (low platelet count) can be associated with leukemia. However, the presence of anemia warrants further investigation, as it could stem from various causes, including nutritional deficiencies, chronic disease, or bone marrow issues.

In terms of follow-up care, it is generally recommended that childhood leukemia survivors have regular check-ups with a hematologist or oncologist. These visits typically include blood tests to monitor blood counts and assess overall health. Depending on your specific situation, your doctor may recommend additional tests or imaging studies to ensure that there are no underlying issues.

In summary, while the concern for recurrence is valid, it is essential to approach it with a comprehensive evaluation by a specialist. They can provide clarity on your current health status and the appropriate next steps. Regular follow-up care is crucial for monitoring and addressing any potential health issues early on. Remember, many childhood leukemia survivors lead healthy, fulfilling lives, and staying informed and proactive about your health is the best approach.

Similar Q&A

Is There a Link Between Childhood Leukemia and Adult Brain Tumors?

I have a cousin who was diagnosed with leukemia at the age of 3 or 4 and has since been cured. Follow-up results show that he has not relapsed. Now, at 24 years old, he suddenly developed a brain tumor last year, which was surgically removed, but this year, another brain tumor ha...

Dr. Fan Sheng reply Oncology
Tina: Malignant brain tumors are indeed difficult to completely resect, so the chance of recurrence is significant. As for the relationship with blood cancer, if the patient was treated for acute lymphoblastic leukemia years ago and underwent radiation therapy to the brain to eli...

Life After Acute Myeloid Leukemia: Navigating Recovery and Daily Activities

Hello Dr. Hu, I was diagnosed with M3 type acute promyelocytic leukemia (APL) in January. After six months of treatment (induction + consolidation), my genetic testing is now negative, and my white blood cell count (5000) and platelet count (295) have returned to normal levels, a...

Dr. Hu Ziren reply Oncology
After the treatment, you can resume your normal lifestyle and diet.

Survival Rates After Relapse of Acute Lymphoblastic Leukemia Post-Transplant

Acute Lymphoblastic Leukemia (ALL, pre-B) has a reported success rate of about 50% for the first transplant, and if there is a relapse after an allogeneic stem cell transplant, the prognosis can vary. The five-year survival rate after a mini-transplant (lymphocyte infusion) is ge...

Dr. Chen Yunfang reply Oncology
Hello: Since you did not provide the patient's "age" or "how long after the transplant the relapse occurred," I will summarize the current clinical literature findings: 1. If the patient is a child and relapses within a year and a half post-transplant, th...

Navigating Treatment Decisions for Rare Pediatric Tumors: A Parent's Dilemma

Dear Director Qian, I have previously sent the same inquiry but have not yet received a response, so I am reaching out again. I apologize for the inconvenience! Our main concern is whether, after three years of continuous monitoring with normal results, we should still follow th...

Dr. Qian Xinnan reply Rare Disease
After three years of regular follow-up with no abnormalities, it is appropriate to continue rigorous monitoring as described. At that time, the clinical group was classified as Group I/FH. According to current pediatric cancer treatment guidelines, the chemotherapy agents used in...